195 related articles for article (PubMed ID: 113218)
1. Biliary lipid composition during treatment with different hypolipidaemic drugs.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
[TBL] [Abstract][Full Text] [Related]
2. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
3. Bile acid metabolism in hyperlipoproteinaemia.
Hellström K; Einarsson K
Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
[No Abstract] [Full Text] [Related]
4. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
Kutz K; Schulte A
Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
[TBL] [Abstract][Full Text] [Related]
5. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
[No Abstract] [Full Text] [Related]
6. Lipid lowering drugs and hyperlipidaemia.
Levy RI; Rifking BM
Drugs; 1973; 6(1):12-45. PubMed ID: 4361281
[No Abstract] [Full Text] [Related]
7. [Hyperlipoproteinemia].
Meinders AE
Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
[No Abstract] [Full Text] [Related]
8. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypolipidemic drugs on bile acid metabolism in man.
Miettinen TA
Adv Lipid Res; 1981; 18():65-97. PubMed ID: 6275661
[No Abstract] [Full Text] [Related]
10. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
[TBL] [Abstract][Full Text] [Related]
11. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1981 Jun; 11(3):185-9. PubMed ID: 6791937
[TBL] [Abstract][Full Text] [Related]
12. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
Mann JI; Harding PA; Turner RC; Wilkinson RH
Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
[TBL] [Abstract][Full Text] [Related]
14. Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
Lehtonen A; Viikari J
Acta Med Scand; 1977; 202(3):179-81. PubMed ID: 333869
[TBL] [Abstract][Full Text] [Related]
15. Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemia.
Angelin B; Einarsson K; Leijd B
Eur J Clin Invest; 1984 Feb; 14(1):73-8. PubMed ID: 6421601
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
17. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
Casdorph HR
Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092
[No Abstract] [Full Text] [Related]
18. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
Watermeyer GS; Mann JI; Truswell AS; Levy I
S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
[TBL] [Abstract][Full Text] [Related]
19. Effect of cholestyramine on tissue pools of cholesterol a preliminary report.
Kudchodkar BJ; Sodhi HS; Horlick L; Nazir DJ
Proc Soc Exp Biol Med; 1975 Feb; 148(2):393-6. PubMed ID: 1121487
[TBL] [Abstract][Full Text] [Related]
20. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
Turley SD; Dietschy JM
J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
